| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/08/2003 | CN1390210A Process for preparing oxazolines from tetrahydrofurans |
| 01/08/2003 | CN1390209A Use of benzotriazole UV absorbers |
| 01/08/2003 | CN1390206A Inhibitors of factor Xa |
| 01/08/2003 | CN1390205A Novel compound |
| 01/08/2003 | CN1390203A Novel 5-pyrimidine carboxamide derivatives and the pharmaceutical compositions containing said derivatives |
| 01/08/2003 | CN1390201A Cyclic amine compounds as CCR5-antagonists |
| 01/08/2003 | CN1390200A Inhibitors of metalloproteinases |
| 01/08/2003 | CN1390196A Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 01/08/2003 | CN1390194A Stable salts of novel derivatives of 3,3-diphenylpropylamines |
| 01/08/2003 | CN1390193A Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 01/08/2003 | CN1390191A Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
| 01/08/2003 | CN1390149A System and device for preventing restenosis in body vessels |
| 01/08/2003 | CN1390143A Amphiphilic prodrugs |
| 01/08/2003 | CN1390142A Taxane prodrugs |
| 01/08/2003 | CN1390139A Oncolytic combinations for the treatment of cancer |
| 01/08/2003 | CN1390133A Composition for stabilizing corneal tissue during or after orthokeratology lens wear |
| 01/08/2003 | CN1390130A Glucosamine and egg for reducing inflammation |
| 01/08/2003 | CN1390129A Solutions containing epinastine |
| 01/08/2003 | CN1390128A Use of adatanserin for treating neurogenerative disorders |
| 01/08/2003 | CN1390127A Antifungal oral composition containing itraconazole and process for preparing same |
| 01/08/2003 | CN1390126A Methods of treating and/or suppressing weight gain |
| 01/08/2003 | CN1390125A High lipid diet |
| 01/08/2003 | CN1390124A Medicine for preventing or treating myopia |
| 01/08/2003 | CN1390123A Method for treating or preventing myopia using iNOS inhibitor |
| 01/08/2003 | CN1390122A Tissue factor antagonists and methods of use thereof |
| 01/08/2003 | CN1390121A Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 01/08/2003 | CN1390119A Process for making aqueous coated beadlets |
| 01/08/2003 | CN1390118A Dextrose and insulin fluid formulation for intravenous infusion |
| 01/08/2003 | CN1390096A Compositions, Kits and methods for providing and maintaining energy and mental alertness |
| 01/08/2003 | CN1390091A Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and composition containing the same |
| 01/08/2003 | CN1389475A Wolfberry polysaccharide and its prepn. and application |
| 01/08/2003 | CN1389463A Condensed triheterocyclic compound |
| 01/08/2003 | CN1389458A P-methylsulfonyl phenylacrylate derivative and its prepn process and anti-inflammatory effect |
| 01/08/2003 | CN1389267A Recipe and prepn. of medicine for treating diabetes and ulcer |
| 01/08/2003 | CN1389250A Composite medicine for improving memory and intelligence |
| 01/08/2003 | CN1389241A Composite medicine for treating hircus, tinea and external piles |
| 01/08/2003 | CN1389239A Complete granule for treating hepatocirrhosis and liver ascites and its prepn. |
| 01/08/2003 | CN1389213A Composite eye-moistening liquid and its application |
| 01/08/2003 | CN1389212A Bupleurum flavone composition for resisiting influenza virus and its prepn. |
| 01/08/2003 | CN1389211A Puerarin injection and its prepn. process |
| 01/08/2003 | CN1389210A Application of sophoricoside |
| 01/08/2003 | CN1389209A Myocarditis treating medicine |
| 01/08/2003 | CN1389208A Orally taken pulsed releasing system of phenyl diazepine medicine and its prepn. |
| 01/08/2003 | CN1389207A Tetradic injection for treating hepatocirrhosis and liver ascites and its compounding process |
| 01/08/2003 | CN1389206A Cataract-resisting eye medicament and the ophthalmic application of corneal osmosis promoter azone |
| 01/08/2003 | CN1389205A Soft bilobalide capsule and its prepn. |
| 01/08/2003 | CN1389204A Chinese medicine extract for treating hepatitis and its prepn. |
| 01/08/2003 | CN1389203A Method for treating hair-dropping using thyromimetic compound |
| 01/08/2003 | CN1389202A Levo-salbutamol hydrochloride aerosol and its prepn. |
| 01/08/2003 | CN1389201A New use of coenzyme Q10 |
| 01/08/2003 | CN1389200A Dexamethasone acetate plaster and its prepn. |
| 01/08/2003 | CN1389199A Slow-releasing Tamoxifen citrate tablet |
| 01/08/2003 | CN1098266C Fused pyrrolo (2,3-c) carbazole-6-one which potentiate activity of gamma interferon |
| 01/08/2003 | CN1098264C Substituted 4-(1H-benzimidzol-2-yl-amino) piepridines useful for the treatment of allergic diseases |
| 01/08/2003 | CN1098263C Pyridin-2-yl-methylaminederivatives, method of preparing and application as medicine |
| 01/08/2003 | CN1098260C 2,4-diaminopyrimidine derivatives |
| 01/08/2003 | CN1098259C Novel carboxy substituted cyclic carboxamide derivatives |
| 01/08/2003 | CN1098258C Isocoumarin derivatives and use thereof in drugs |
| 01/08/2003 | CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
| 01/08/2003 | CN1098255C Novel substituted piperazine derivatives having tachyknin receptor antagonists activity |
| 01/08/2003 | CN1098254C Sulfonamides |
| 01/08/2003 | CN1098249C Use of ubimec or medicinal composition containing ubimec for treatment virus hepatitis |
| 01/08/2003 | CN1098104C New oral pharmaceutical dosage form |
| 01/08/2003 | CN1098100C Chinese medicine powder for treating hypertension and arteriosclerosis |
| 01/08/2003 | CN1098097C External-use ointment for treating burns and scalds |
| 01/08/2003 | CN1098082C Pudenda cleaning liquid and its production process and application |
| 01/08/2003 | CN1098081C Compound urea drops for ear |
| 01/08/2003 | CN1098080C Ear drops |
| 01/08/2003 | CN1098079C Medicinal liquid for treating ligagmentum sacrotuberosum disease |
| 01/08/2003 | CN1098078C Composition for preventing and treating bacterial diseases of young chicken |
| 01/08/2003 | CN1098077C Oral liquor for treating calf diarrhoea and its preparation method |
| 01/08/2003 | CN1098076C Broad-spectrum antifungal oral medicine for treating skin soft tissue infection and syphilitic clap |
| 01/08/2003 | CN1098075C Broad-spectrum antibacterial medicine and its exterior application method |
| 01/08/2003 | CN1098074C Topical ketoconazole emulsions |
| 01/08/2003 | CN1098073C Bee pollination inducing agent |
| 01/08/2003 | CN1098072C Medicinal product of superfined alpha-linolenic acid, preparing process and preparation thereof |
| 01/08/2003 | CN1098071C Transdermal device for delivery of flurbiprofen |
| 01/08/2003 | CN1098070C Guanylhydrazones for treating inflammatory conditions |
| 01/08/2003 | CN1098069C Transdermal device for delivery of flurbiprofen |
| 01/07/2003 | US6504057 Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/07/2003 | US6504052 Excitatory amino acid receptor modulators |
| 01/07/2003 | US6504035 3-deoxy-desmycosin derivatives and process for their preparation |
| 01/07/2003 | US6504034 Cell antiproliferative agents; anticancer agents |
| 01/07/2003 | US6504030 Polymorphic form of clopidogrel hydrogen sulphate |
| 01/07/2003 | US6504028 Process for preparing benzoxazin-4-one polymer conjugates |
| 01/07/2003 | US6504026 Process for production of ceftiofur |
| 01/07/2003 | US6504025 In fewer steps and is obtained in higher yield; chemical intermediates; useful in treating methicillin resistent Staphylococcus aureus and Pseudomonas aeruginosa |
| 01/07/2003 | US6504017 Erthromycin a oxime solvates |
| 01/07/2003 | US6504014 Tissue specific prodrug |
| 01/07/2003 | US6504007 GDNF receptor |
| 01/07/2003 | US6503953 Methods for treating atopic disorders |
| 01/07/2003 | US6503951 Administering active substance selected from creatine, derivatives and combinations thereof in a dosage which reduces or eliminates typical disorders |
| 01/07/2003 | US6503950 Kit for treatment of alcohol withdrawal symptoms comprising three separate ingredients: at least one anxiolytic agent; at least one centrally acting alpha antiadrenergic agent; and at least one central nervous system stimulant agent |
| 01/07/2003 | US6503948 1-(2-haloethyl)-1-nitroso-(cyclohexyl)urea derivatives are useful for reducing acute allograft rejection by recipient |
| 01/07/2003 | US6503947 Method of treating cytotoxic damage |
| 01/07/2003 | US6503946 Preparation for warts |
| 01/07/2003 | US6503945 Nontoxic, drug delivery, gene therapy; therapy of cystic fibrosis |
| 01/07/2003 | US6503943 Antitumor agents |
| 01/07/2003 | US6503940 Prodrugs for antimicrobial amidines |
| 01/07/2003 | US6503939 Combination regimens using 3,3-substituted indoline derivatives |